Financhill
Back

Realty Income Corp. Vs. Halozyme Therapeutics, Inc. Industry Stock Comparison

Sell
35

O
Realty Income Corp.

Last Price:
$56.79
Seasonality Move:
1.83%
Buy
65

HALO
Halozyme Therapeutics, Inc.

Last Price:
$69.17
Seasonality Move:
5.49%
Sell
35
Realty Income Corp. (O) is a Sell

Is Realty Income Corp. a Buy, Sell or Hold?

  • The current Realty Income Corp. [O] share price is $56.69. The Score for O is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • O is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Halozyme Therapeutics, Inc. (HALO) is a Buy

Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Halozyme Therapeutics, Inc. [HALO] share price is $68.87. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

O Stock Price Chart

What is Realty Income Corp.'s stock price today?

  • The Realty Income Corp. share price today is $56.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and O is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics, Inc.'s stock price today?

  • The Halozyme Therapeutics, Inc. share price today is $68.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

O Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 45.95 Sell
Chaikin Money Flow: 1307589 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.51 - 57.81) Sell
Bollinger Bands (100): (56.99 - 59.67) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 58.98 Buy
Chaikin Money Flow: 516593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.07 - 70.31) Buy
Bollinger Bands (100): (64.7 - 73.66) Sell

O Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.78 Sell
20-day SMA: 57.28 Sell
50-day SMA: 57.64 Sell
200-day SMA: 57.52 Sell
8-day EMA: 56.76 Sell
20-day EMA: 57.05 Sell
50-day EMA: 57.52 Sell
200-day EMA: 57.61 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.06 Buy
20-day SMA: 65.42 Buy
50-day SMA: 67.19 Buy
200-day SMA: 63.54 Buy
8-day EMA: 67.24 Buy
20-day EMA: 66.58 Buy
50-day EMA: 67.18 Buy
200-day EMA: 63.87 Buy

Realty Income Corp. Earnings Growth & O Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.25 per share.

Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.13 per share, and an increase next year of $1.88 per share.

Realty Income Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):